We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+31.89%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
-$18.2M
(-0.99%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-24.46%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
396
New
38
Increased
53
Reduced
183
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$24.1M |
| 2 |
Parker-Hannifin
PH
|
+$20.9M |
| 3 |
Ameriprise Financial
AMP
|
+$15.8M |
| 4 |
THS
Treehouse Foods
THS
|
+$12.2M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$48.5M |
| 2 |
Microsoft
MSFT
|
+$45.5M |
| 3 |
Biogen
BIIB
|
+$36M |
| 4 |
Amazon
AMZN
|
+$29.7M |
| 5 |
Burlington
BURL
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.49% |
| 2 | Healthcare | 16.85% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Communication Services | 8.43% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
126
DELISTED
PRA Health Sciences, Inc.
PRAH
| $562K | 0.03% |
5,778
-89,190
| -94% | -$8.3M |
|
127
Collegium Pharmaceutical
COLL
$882M
| $556K | 0.03% |
31,755
-19,758
| -38% | -$387K |
|
|
AMED
128
DELISTED
Amedisys
AMED
| $522K | 0.03% |
2,627
-46
| -2% | -$8.58K |
|
129
Comfort Systems
FIX
$58.9B
| $511K | 0.03% |
12,531
-44
| -0.3% | -$1.56K |
|
130
Turkcell
TKC
$4.79B
| $508K | 0.03% |
88,250
| – | – |
|
131
UFP Industries
UFPI
$5.01B
| $502K | 0.03% |
10,130
-150
| -1% | -$6.39K |
|
132
Lantheus
LNTH
$6.59B
| $501K | 0.03% |
35,064
-151
| -0.4% | -$2K |
|
|
UCB
133
United Community Banks
UCB
$4.27B
| $457K | 0.03% |
22,726
-78
| -0.3% | -$1.49K |
|
|
SYNH
134
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $452K | 0.02% |
7,760
-110
| -1% | -$5.91K |
|
|
BMCH
135
DELISTED
BMC Stock Holdings, Inc
BMCH
| $450K | 0.02% |
17,900
-230
| -1% | -$5.09K |
|
|
HMSY
136
DELISTED
HMS Holdings Corp.
HMSY
| $446K | 0.02% |
13,760
-100
| -0.7% | -$2.89K |
|
137
Sportsman's Warehouse
SPWH
$46.4M
| $439K | 0.02% |
+30,830
| New | +$290K |
|
138
CONMED
CNMD
$1.48B
| $424K | 0.02% |
5,892
-21
| -0.4% | -$1.46K |
|
139
Central Garden & Pet Co
CENT
$2.75B
| $421K | 0.02% |
+14,613
| New | +$393K |
|
140
Tetra Tech
TTEK
$8.97B
| $418K | 0.02% |
26,400
-350
| -1% | -$5.32K |
|
141
EverQuote
EVER
$900M
| $391K | 0.02% |
+6,730
| New | +$316K |
|
|
NPTN
142
DELISTED
NEOPHOTONICS CORP
NPTN
| $385K | 0.02% |
43,350
+14,520
| +50% | +$125K |
|
143
Walker & Dunlop
WD
$1.49B
| $384K | 0.02% |
7,550
-100
| -1% | -$4.09K |
|
|
HIBB
144
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $381K | 0.02% |
18,214
-230
| -1% | -$3.83K |
|
|
PRTK
145
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $378K | 0.02% |
72,400
-1,040
| -1% | -$4.62K |
|
146
Atkore
ATKR
$3.17B
| $377K | 0.02% |
13,774
-190
| -1% | -$4.7K |
|
147
Integer Holdings
ITGR
$4.25B
| $370K | 0.02% |
5,070
-60
| -1% | -$4.36K |
|
148
Stock Yards Bancorp
SYBT
$2.58B
| $369K | 0.02% |
9,178
-6,630
| -42% | -$216K |
|
149
Ziff Davis
ZD
$2B
| $366K | 0.02% |
6,659
-80
| -1% | -$5.23K |
|
150
OSI Systems
OSIS
$3.83B
| $316K | 0.02% |
4,240
-60
| -1% | -$4.38K |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Smith Group Asset Management held 396 positions worth $1.81B, down 0.99% from $1.83B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Smith Group Asset Management withdrew a net $444M in Q2 2020, closing 98 positions and reducing 183 holdings. Its most notable exit was Biogen, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Smith Group Asset Management opened a new position in Hologic worth $28M.
- Smith Group Asset Management's largest Q2 2020 buy was Hologic: 490,762 shares worth $28M.
- Smith Group Asset Management added most to Ameriprise Financial in Q2 2020, an estimated $15.8M increase.
- Smith Group Asset Management's biggest Q2 2020 reduction was Apple, cutting an estimated $48.5M.
- Smith Group Asset Management fully exited Biogen in Q2 2020, selling an estimated $36M.
- Smith Group Asset Management's ten largest holdings make up 40% of its $1.81B portfolio in Q2 2020.
- Smith Group Asset Management opened 38 new positions and closed 98 in Q2 2020.
- Smith Group Asset Management's portfolio value fell 0.99% quarter-over-quarter to $1.81B.
Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.